ACC/AHA guidelines: A-, B-, C-, and D-based approach to chronic heart failure therapy

European Heart Journal, Supplement

Volumn 8, Issue E, 2006, Pages

  Hunt, Sharon A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Guidelines; Heart failure therapy

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FELODIPINE; HYDRALAZINE; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ASSISTED CIRCULATION; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATOR; DISEASE EXACERBATION; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HEART TRANSPLANTATION; HEART VENTRICLE REMODELING; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SURGICAL APPROACH; SYMPTOMATOLOGY; TREATMENT INDICATION;

EID: 33748760062     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/sul023     Document Type: Review

References (6)

1. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 1997;133:703-712.
2. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats, TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2001;38:2102-2113.
3. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, Smiseth OA. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115-1140.
4. The Criteria Committee of the New York Heart Association. Diseases of the Heart and Blood Vessels: Nomenclature and Criteria for Diagnosis. 6th ed. Boston, MA: Little Brown; 1964.
5. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327:685-691.
6. Hunt SA, Abraham WT, Chin MH et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure in the Adult) American College of Cardiology Web Site 2005, http://acc.org.